BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23899996)

  • 1. Issues in selection of instruments to measure negative symptoms.
    Daniel DG
    Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Negative symptoms: clinical and psychometric aspects].
    Adida M; Azorin JM; Belzeaux R; Fakra E
    Encephale; 2015 Dec; 41(6 Suppl 1):6S15-7. PubMed ID: 26776385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining and measuring negative symptoms of schizophrenia in clinical trials.
    Marder SR; Kirkpatrick B
    Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools to assess negative symptoms in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
    Mach C; Dollfus S
    Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
    Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of the negative syndrome of schizophrenia.
    Garcia-Portilla MP; Garcia-Alvarez L; Saiz PA; Al-Halabi S; Bobes-Bascaran MT; Bascaran MT; Muñiz J; Bobes J
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):559-66. PubMed ID: 25802109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brief Negative Symptom Scale: Validation in a multicenter Brazilian study.
    de Medeiros HLV; Vasconcelos SC; Elkis H; Martins DR; de Alexandria Leite RM; de Albuquerque ACL; Freitas RR; Scardoelli MA; Di Sarno E; Napolitano I; Oliveira GM; Vizzotto A; da Silva AMP; da Costa Lima MD
    Compr Psychiatry; 2018 Aug; 85():42-47. PubMed ID: 29966891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
    Velligan DI; Alphs L; Lancaster S; Morlock R; Mintz J
    Psychiatry Res; 2009 Sep; 169(2):97-100. PubMed ID: 19664826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brief negative symptom scale in translation: A review of psychometric properties and beyond.
    Tatsumi K; Kirkpatrick B; Strauss GP; Opler M
    Eur Neuropsychopharmacol; 2020 Apr; 33():36-44. PubMed ID: 32081498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
    Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polish version of the Brief Negative Symptom Scale (BNSS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Gołębiewska K; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):541-549. PubMed ID: 31522195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
    Strauss GP; Keller WR; Buchanan RW; Gold JM; Fischer BA; McMahon RP; Catalano LT; Culbreth AJ; Carpenter WT; Kirkpatrick B
    Schizophr Res; 2012 Dec; 142(1-3):88-92. PubMed ID: 23127378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.